Business NewsPR NewsWire • AIVITA Biomedical CEO Dr. Hans Keirstead to Chair Keynote Panel and Deliver Talk at World Immunotherapy Congress Europe

AIVITA Biomedical CEO Dr. Hans Keirstead to Chair Keynote Panel and Deliver Talk at World Immunotherapy Congress Europe

AIVITA Biomedical CEO Dr. Hans Keirstead to Chair Keynote Panel and Deliver Talk at World Immunotherapy Congress Europe

IRVINE, Calif., Nov. 8, 2021 /PRNewswire/ -- AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, today announced that chairman and CEO Dr. Hans S. Keirstead will chair a keynote panel and speak on consecutive days at the World Immunotherapy...

View More : https://www.prnewswire.com:443/news-releases/aivita-biomedical-ceo-dr-hans-keirstead-to-chair-keynote-panel-and-deliver-...
Releted News by prnewswire
Medical Cannabis Market to Reach $53.88 Bn, Globally, by 2030 at 23.6% CAGR: Allied Market Research
AIVITA Biomedical CEO Dr. Hans Keirstead to Chair Keynote Panel and Deliver Talk at World Immunotherapy Congress Europe
Oramed Announces Closing of $50 Million Registered Direct Offering of Common Stock Priced At-the-Market Under Nasdaq Rules
Redfin to Present at 1st Annual Needham Consumer Tech / E-Commerce Virtual Conference